Achieving system readiness for radioligand therapy in the UK: the event as it happened

Achieving system readiness for radioligand therapy in the UK: the event as it happened

On 9 September, The Health Policy Partnership (HPP) was pleased to host a webinar to launch the UK situation analysis report and policy action blueprint.
Read More
Radioligand Therapy Readiness Assessment Framework launched at event with esteemed speakers

Radioligand Therapy Readiness Assessment Framework launched at event with esteemed speakers

On 9 June 2021, the new Radioligand Therapy Readiness Assessment Framework was launched at an event with a panel of international and multidisciplinary experts.
Read More
New poster on radioligand therapy readiness published at virtual ESMO congress

New poster on radioligand therapy readiness published at virtual ESMO congress

The Health Policy Partnership and Professor Ken Herrmann have published a poster at the virtual European Society for Medical Oncology (ESMO) congress 2020.
Read More
Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms

Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms

The Health Policy Partnership has published a poster at the 10th European Conference on Rare Diseases & Orphan Products (ECRD).
Read More
New poster published at ENETS virtual conference

New poster published at ENETS virtual conference

The Health Policy Partnership presented a poster on radioligand therapy at the European Neuroendocrine Tumor Society (ENETS) conference.
Read More
Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan

Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan

Recommendations from the radioligand therapy policy report have formed the basis of a submission to Europe’s Beating Cancer Plan, addressing the burden of cancer in the EU.
Read More
Policy report on radioligand therapy launched at European Parliament

Policy report on radioligand therapy launched at European Parliament

On 22 January 2020, The Health Policy Partnership and an expert-led steering committee launched a policy report on radioligand therapy at the European Parliament.
Read More